These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2941890)

  • 1. [Hormonal contraception using depot preparations].
    Keller PJ
    Ther Umsch; 1986 May; 43(5):395-9. PubMed ID: 2941890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parenteral contraceptive drugs: depot progestins].
    Rabe T; Runnebaum B
    Wien Med Wochenschr; 1987 Nov; 137(20-21):474-9. PubMed ID: 2967589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Real and false risks of injectable hormonal contraception].
    Revaz C
    Gynakol Rundsch; 1984; 24 Suppl 1():20-5. PubMed ID: 6240435
    [No Abstract]   [Full Text] [Related]  

  • 4. New delivery systems for hormonal contraception.
    Odlind V
    Acta Obstet Gynecol Scand Suppl; 1986; 134():15-20. PubMed ID: 2949479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Injectable contraception using depot progestagens].
    Velasco Murillo V; Correu Azcona S
    Ginecol Obstet Mex; 1983 Jul; 51(315):191-7. PubMed ID: 6242048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of injectable contraceptives in Mexican women].
    Garza-Flores J; Rodríguez V; Cravioto MC; del Real Mora O; Anderson J; Landeros J; Díaz Sánchez V; Lichtenberg R; Pérez-Palacios G
    Bol Oficina Sanit Panam; 1985 Feb; 98(2):181-6. PubMed ID: 3156612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    Levine JP
    J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting progestins--promise and prospects.
    Popul Rep K; 1983 May; 11(2):K17-55. PubMed ID: 6222930
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
    Amatayakul K; Suriyanon V
    Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in hormonal contraception.
    Gupta N
    Adolesc Med Clin; 2006 Oct; 17(3):653-71; abstract xi. PubMed ID: 17030284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medroxyprogesterone acetate. Biochemical and clinical aspects].
    Ayala AR; Almazań M
    Ginecol Obstet Mex; 1982 Sep; 50(305):253-9. PubMed ID: 6226570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological and clinical application of progestational hormone depot preparations].
    Andor J
    Gynakol Rundsch; 1978; 18(3-4):163-71. PubMed ID: 569621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    Beksinska ME; Rees HV
    Afr J Reprod Health; 2001 Dec; 5(3):84-8. PubMed ID: 12471932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting injectable contraceptives.
    Vecchio TJ
    Adv Steroid Biochem Pharmacol; 1976; 5():1-64. PubMed ID: 779431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive options for women in selected circumstances.
    Weisberg E
    Best Pract Res Clin Obstet Gynaecol; 2010 Oct; 24(5):593-604. PubMed ID: 20434405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doctors and injectable contraception. Analysis of the logistics of prescribing in accordance with the views expressed by doctors].
    Herschkorn P; Thebaud-Mony A; Lasselain J; Bretin H
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):228-36. PubMed ID: 2139070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.